Coverage
-
January 04, 2021
In an interview with Law360, the U.S. Department of Justice attorneys who prosecuted Indivior and two executives for illicit opioid marketing spotlighted the unusually strict compliance rules now hanging over the company and pointedly contrasted Indivior's no-holds-barred legal defense with the cooperative approaches of drugmakers in other cases.
12 other articles on this case.
View all »